# Southern California Center for Reproductive Medicine – FDA Inspection, Jan 20, 2023

Source: https://www.keypedia.com/records/fda_inspections/southern-california-center-for-reproductive-medicine/8f343360-e705-4975-a822-adf477a3ab2c
Source feed: FDA_Inspections

> FDA inspection 1195219 of Southern California Center for Reproductive Medicine, January 20, 2023. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 1271. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195219
- Company Name: Southern California Center for Reproductive Medicine
- Inspection Date: 2023-01-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 6

## Related Documents

- [FDA Inspection 1224963 - 2023-12-13](https://www.keypedia.com/records/fda_inspections/southern-california-center-for-reproductive-medicine/de6a2904-3889-459c-905a-e8c57ce1f93d)
- FDA Inspection 984893 - 2016-09-01
- FDA Inspection 695229 - 2010-10-27

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/celeta-s-coves/d0f63577-a6e4-4872-b06c-a024188a04ba)

Company: https://www.keypedia.com/companies/southern-california-center-for-reproductive-medicine/0dfcf918-5299-4364-bcee-9a05e8a21647

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
